| Aaron S Kesselheim | Queen's University, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, A.S.K.) and the Section of General Medicine and the National Clinician Scholars Program, Yale School of Medicine, Yale School of Public Health - both in New Haven |